Verition Fund Management LLC Astrazeneca PLC Transaction History
Verition Fund Management LLC
- $21.7 Billion
- Q3 2025
A detailed history of Verition Fund Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Verition Fund Management LLC holds 6,562 shares of AZN stock, worth $586,642. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,562
Previous 22,356
70.65%
Holding current value
$586,642
Previous $1.56 Million
67.8%
% of portfolio
0.0%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding AZN
# of Institutions
1,510Shares Held
501MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...